Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- M-Mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study).Am J Cardiol. 2001; 87: 1051-1057
- Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study.J Am Coll Cardiol. 2001; 38: 1829-1835
- Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death.J Am Coll Cardiol. 1998; 32: 1454-1459
- Standardization of M-mode echocardiographic left ventricular anatomic measurements.J Am Coll Cardiol. 1984; 4: 1222-1230
- Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction.Am J Cardiol. 2006; 98: 1396-1399
- Depressive symptoms and health-related quality of life: the Heart and Soul Study.JAMA. 2003; 290: 215-221
- Recommendations for quantitation of the left ventricle by two-dimensional echocardiography.J Am Soc Echocardiogr. 1989; 2: 358-367
- Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.J Am Soc Echocardiogr. 2005; 18: 1440-1463
- The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension.J Am Coll Cardiol. 1986; 7: 639-650
- The cardiovascular risk factor, left ventricular hypertrophy, is highly prevalent in stable, treated angina pectoris.Am J Hypertens. 2007; 20: 1029-1035
- Proportional hazards tests and diagnostics based on weighted residuals.Biometrika. 1994; 81: 515-526
- Partial residuals for the proportional hazards regression model.Biometrika. 1982; 69: 239-241
- Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study.J Am Coll Cardiol. 2006; 47: 1161-1166
- Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).J Am Coll Cardiol. 2005; 46: 1712-1720
- Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.J Am Coll Cardiol. 2002; 40: 2156-2164
- Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.J Am Coll Cardiol. 2003; 41: 1561-1567
- Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.N Engl J Med. 2000; 342: 1778-1785
- Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group.J Am Coll Cardiol. 2006; 48: 765-771
- Microvolt T wave alternans in human cardiac hypertrophy: electrical instability and abnormal myocardial arrangement.J Cardiovasc Electrophysiol. 2001; 12: 759-763
Dr. Turakhia was supported by grants from the American College of Cardiology and Merck Foundation. The Heart and Soul Study was supported by the Department of Veterans Affairs, the National Heart, Lung and Blood Institute (R01 HL079235), the American Federation for Aging Research, the Robert Wood Johnson Foundation, and the Ischemia Research and Education Foundation.